EpiDisease
PrivateLast Round
VC Round
Apr 15, 2021
Total Funding Raised
$402,480
Momentum
Top 50%
of companies Caplight tracks
Company Overview
EpiDisease is a biotechnology company that develops and commercializes a pipeline of patented genetic and epigenetic in vitro diagnostic (IVD) products and clinical software tools for the precision management of complex human diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EpiDisease Comparables
Compare EpiDisease with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EpigenDx | 79% | |
| Epitype GmbH | 76% | |
| OXFORD BIODYNAMICS LS-01 | 74% |
EpiDisease Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 15, 2021 | ||||
| Grant | Jul 25, 2018 |
EpiDisease Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fundación Botín | VC Round, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 34% MoM.
- Jun 1, 2025
Monthly visitors increased 323% MoM to 2.3K.
EpiDisease Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about EpiDisease's valuation, stock price, and market status.
Is EpiDisease a public or private company?
EpiDisease is a private company.
What is the current stock price of EpiDisease?
EpiDisease is a private company with no public stock price. No recent secondary market data is available.
How much is EpiDisease worth (valuation)?
Valuation information for EpiDisease is not publicly available.
Can I buy EpiDisease stock?
EpiDisease shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was EpiDisease's last funding round?
EpiDisease's most recent funding round was VC Round on April 15, 2021.
Who are the main investors in EpiDisease?
Key investors in EpiDisease include Fundación Botín.
Will EpiDisease IPO soon?
No public IPO plans have been announced for EpiDisease.
How can I track EpiDisease secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EpiDisease's secondary market activity and sign up for updates.